Europlasma (France) Today
| ALEUP Stock | EUR 0.03 0 5.54% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Europlasma is selling at 0.0341 as of the 21st of November 2024; that is 5.54% down since the beginning of the trading day. The stock's last reported lowest price was 0.033. Europlasma has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Europlasma SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of May 2024 and ending today, the 21st of November 2024. Click here to learn more.
Europlasma S.A., together with its subsidiaries, engages in plasma solutions, renewable energies, and asbestos waste treatment activities in France. Europlasma S.A. was founded in 1992 and is based in Pessac, France. EUROPLASMA operates under Waste Management classification in France and is traded on Paris Stock Exchange. The company has 5.59 M outstanding shares. More on Europlasma SA
Moving together with Europlasma Stock
Moving against Europlasma Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Europlasma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Europlasma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Europlasma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Industrials, Commercial Services & Supplies, Waste Management, Industrials (View all Sectors) |
Europlasma SA (ALEUP) is traded on Euronext Paris in France and employs 126 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Europlasma's market, we take the total number of its shares issued and multiply it by Europlasma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Europlasma SA operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 5.59 M outstanding shares.
Europlasma SA has accumulated about 3.92 M in cash with (18.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Europlasma Probability Of Bankruptcy
Europlasma SA Risk Profiles
Although Europlasma's alpha and beta are two of the key measurements used to evaluate Europlasma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.34 | |||
| Standard Deviation | 10.37 | |||
| Variance | 107.58 | |||
| Risk Adjusted Performance | (0.17) |
Europlasma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Europlasma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Additional Tools for Europlasma Stock Analysis
When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.